Astera Labs (NASDAQ:ALAB) Shares Down 2.3% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB) shares fell 2.3% during trading on Friday . The company traded as low as $154.50 and last traded at $159.80. 5,822,778 shares traded hands during trading, an increase of 11% from the average session volume of 5,237,135 shares. The stock had previously closed at $163.55.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ALAB. Bank of America began coverage on shares of Astera Labs in a research report on Friday, October 3rd. They set a “neutral” rating and a $230.00 price target on the stock. Wall Street Zen raised shares of Astera Labs from a “hold” rating to a “buy” rating in a research report on Saturday. Stifel Nicolaus upped their price target on shares of Astera Labs from $174.00 to $185.00 and gave the company a “buy” rating in a research report on Friday. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Finally, Needham & Company LLC increased their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Fifteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $162.06.

Astera Labs Trading Down 2.3%

The company has a market cap of $26.56 billion, a P/E ratio of 285.36, a PEG ratio of 3.98 and a beta of 1.43. The stock’s 50-day moving average price is $199.68 and its 200-day moving average price is $128.30.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million for the quarter, compared to analysts’ expectations of $172.46 million. During the same quarter in the prior year, the firm earned $0.13 EPS. The business’s revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $192.16, for a total value of $1,921,600.00. Following the sale, the general counsel owned 151,573 shares in the company, valued at $29,126,267.68. This represents a 6.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the sale, the director owned 385,863 shares in the company, valued at $66,858,482.01. This represents a 32.17% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,182,514 shares of company stock worth $202,298,671 over the last ninety days. Insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Oliver Lagore Vanvalin Investment Group purchased a new stake in Astera Labs in the 2nd quarter valued at about $29,000. Bernard Wealth Management Corp. purchased a new stake in Astera Labs in the 2nd quarter valued at about $36,000. Clearstead Trust LLC increased its stake in Astera Labs by 46,100.0% in the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after buying an additional 461 shares during the last quarter. Advisors Asset Management Inc. increased its stake in Astera Labs by 68.6% in the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after buying an additional 194 shares during the last quarter. Finally, Manchester Capital Management LLC increased its stake in Astera Labs by 141.5% in the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after buying an additional 283 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.